Gpran Pharma Private Limited
About Gpran Pharma Private Limited
Data last updated:
Gpran Pharma Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the specialised retail segment of the home appliances and consumer durables sector. It was incorporated on 24 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U52311DL2017PTC321118. Its GSTIN is 10AAGCG9356A1Z0 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Binay Kumar Singh (Managing Director) and Mini Kumari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 307 Plot No – 5 Mlu T/F Krishna Mall Sector – 12 Dwarka, New Delhi, Delhi, India – 110078.
As per the financials filed for FY 2025, the company reported a revenue of ₹57.79 Lakh, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹30,635 (net margin 0.5%) and EBITDA of ₹42,510 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years and 104% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address307 Plot No – 5 Mlu T/F Krishna Mall Sector – 12 Dwarka, New Delhi, Delhi, India – 110078
- IndustryHome Appliances, Specialized Stores, Retailers
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Gpran Pharma Private Limited
The main business activity of Gpran Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Gpran Pharma Private Limited FY 2025 filings available
Gpran Pharma Private Limited reported revenue of ₹57.79 Lakh (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Gpran Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 104% over five years, including 10% growth in the latest year. EBITDA rose 17% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Gpran Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹42,510 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹30,635 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Gpran Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Gpran Pharma are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Gpran Pharma Private Limited
Gpran Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| East India Chemical Works Pvt Ltd | ₹57.89 Lakh (FY 2023) | •••• | •••• | 8118.0% | •••• | Kolkata, West Bengal, India |
| Noemi Cosmeceuticals Private Limited | ₹57.88 Lakh (FY 2024) | •••• | •••• | -62.0% | •••• | Mumbai, Maharashtra, India |
| Oredia Therapeutics Private Limited | ₹57.88 Lakh (FY 2025) | •••• | •••• | 47.0% | •••• | Mumbai, Maharashtra, India |
| Xylam Remedies Private Limited | ₹57.86 Lakh (FY 2025) | •••• | •••• | 27.0% | •••• | Raisen, Madhya Pradesh, India |
| Plant Aromatics Private Limited | ₹57.79 Lakh (FY 2024) | •••• | •••• | -57.0% | •••• | Mumbai, Maharashtra, India |
| Gpran Pharma Private Limited this company | ₹57.79 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | New Delhi, Delhi, India |
| Shinton Chemicals Pvt Ltd | ₹57.78 Lakh (FY 2023) | •••• | •••• | 17.0% | •••• | Indore, Madhya Pradesh, India |
| Alisha Kumkum Manufacturing and Trading Private Limited | ₹57.77 Lakh (FY 2023) | •••• | •••• | •••• | Velapur, Maharashtra, India | |
| Unostar Biochem India Private Limited | ₹57.63 Lakh (FY 2024) | •••• | •••• | -4.0% | •••• | Bangalore, Karnataka, India |
| Grameen Agro Producer Company Limited | ₹57.63 Lakh (FY 2025) | •••• | •••• | -30.0% | •••• | Kolkata, West Bengal, India |
| Claritol Private Limited | ₹57.57 Lakh (FY 2022) | •••• | •••• | -37.0% | •••• | Ankleshwar, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Gpran Pharma by revenue in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Gpran Pharma Private Limited
Gpran Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mini Kumari | Director | 24 Jul 2017 | 9 Years 2 Months | Current |
| Binay Kumar Singh | Managing Director | 18 Aug 2021 | 5 Years 1 Months | Current |
| Vivek Kumar Singh Also directs: Bansal Neet Jee Academy Private Limited | Director | 24 Jul 2017 | 9 Years 2 Months | Current |
Ownership and Shareholding of Gpran Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Gpran Pharma Private Limited
Gpran Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Gpran Pharma Private Limited
Employment history and EPFO contributions of people linked to Gpran Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Gpran Pharma Private Limited
Gpran Pharma Private Limited has 5 board changes on record since 2017: 3 appointments and 2 cessations. The latest: Binay Kumar Singh ceased to be Additional Director on 30 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Gpran Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Gpran Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Gpran Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Gpran Pharma Private Limited
Gpran Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAGCG9356A1Z0 | Bihar | Active | 30 Oct 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Gpran Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gpran Pharma Private Limited
Gpran Pharma is an active private limited company based in New Delhi, Delhi, India. The company works in specialized stores, within the home appliances industry. It was incorporated on 24 July 2017 (9+ years old) and is registered under CIN U52311DL2017PTC321118.
Gpran Pharma reported revenue of ₹57.79 Lakh for FY 2025 (up 10% YoY).
Gpran Pharma has 3 current directors:
- Binay Kumar Singh - Managing Director
- Mini Kumari - Director
- Vivek Kumar Singh - Director
Gpran Pharma reported a net profit of ₹30,635 (net margin 0.5%) and EBITDA of ₹42,510 (EBITDA margin 0.7%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Gpran Pharma is 43% over three years and 104% over five years. In the latest year (FY 2025) revenue rose 10%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Gpran Pharma is 10AAGCG9356A1Z0, registered in Bihar.
The CIN (Corporate Identification Number) of Gpran Pharma is U52311DL2017PTC321118. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Gpran Pharma was incorporated on 24 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Gpran Pharma by revenue are East India Chemical Works Pvt Ltd, Noemi Cosmeceuticals Private Limited, Oredia Therapeutics Private Limited, Xylam Remedies Private Limited, Plant Aromatics Private Limited and 5 more, all in the same principal business activity (Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Binay Kumar Singh ceased to be Additional Director on 30 Nov 2021. Binay Kumar Singh was appointed as Managing Director on 18 Aug 2021. Kiran Singh ceased to be Director on 23 Jan 2021. Gpran Pharma has 5 board changes on record in total.
The registered office of Gpran Pharma is at 307 Plot No – 5 Mlu TF Krishna Mall Sector – 12 Dwarka, New Delhi, Delhi, India – 110078.